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Health economists have traditionally quantified the burden of vector-borne diseases (such as 
chikungunya and dengue) as the sum of the cost of illness and the cost of intervention programmes. 
The objective of this paper is to predict the order of magnitude of possible reduction in tourism 
revenues if a major epidemic of chikungunya or dengue were to discourage visits by international 
tourists, and to prove that even a conservative estimate can be comparable to or even greater than 
the cost of illness and intervention programmes combined, and therefore should not be ignored in the 




We have chosen three Asian economies where the immediate costs of these diseases have been 
recently calculated: Gujarat (an economically important state of India), Malaysia, and Thailand. 
Only international tourists from non-endemic countries have been considered to be discouraged, and 
a 4% annual decline in their numbers has been assumed. Revenues from these tourists have been 
calculated assuming that tourists from non-endemic countries would spend, on average, the same 
amount as all international tourists. These assumptions are conservative and consistent with the 
recent experience of Mauritius and Réunion islands. Non-Resident Indians (NRIs) have been 
considered half as likely to avoid travel to Gujarat compared to non-Indians. This paper reports 
inflation-adjusted expenditure figures as 2008 US$, assuming recent market exchange rates of 42.0 
INR/US$, 3.22 MYR/US$, 0.68 EUR/US$, and 33.6 THB/US$. 
 
Findings 
A 4% decline in tourists from non-endemic countries would result in a substantial loss of tourism 
revenues – at least US$ 8 million for Gujarat, US$ 65 million for Malaysia, and US$ 363 million for 
Thailand. The estimated immediate annual cost of chikungunya and dengue to these economies is 
US$ 90 million, US$ 133 million, and approximately US$ 127 million respectively, indicating that 
impact on tourism revenues should not be ignored when calculating the burden of infectious diseases. 
The impact on Gujarat is relatively less because its share of world tourism receipts is just 0.04%, 
whereas Malaysia and Thailand have healthy shares of 1.64% and 1.82% respectively. A 4% decline 
in tourists to Gujarat from other Indian states would amount to US$ 9.6 million loss in domestic 
tourism revenues to Gujarat. 
Interpretation 
This paper shows that potential loss of tourism revenues due to a severe epidemic outbreak could be 
substantial. In some cases, ignoring this component could seriously underestimate cost-benefit 
results, forestalling promising interventions that could benefit the society as a whole or leading to 
inadequate investment of resources in prevention and public-funded control programmes. This would 
be to the detriment of especially poorer sections of the society, who may not be able to afford 
treatment costs. At present data are insufficient for us to make more than a preliminary estimate of 
the magnitude of the potential loss of revenues from tourism due to a major outbreak of chikungunya 
or dengue. 
Key words: Chikungunya; Cost of illness; Cost of intervention programmes; Dengue; Disease 
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Vector‐borne  diseases  such  as  chikungunya  and  dengue  have  become  a  major  public  health 








factors  as  discussed  in  section  1.2.  The  cost  of  illness  includes  both  direct  and  indirect  costs 
associated with ambulatory and hospitalised cases, and it is also important to consider reported as 
well as unreported cases (Murtola et al. 2008). Direct costs comprise of medical costs (diagnostics, 

















factors  such  as  mortality  (Mavalankar  et  al.  2008),  long‐term  morbidity  and  other  effects  on 
individuals  (Lum  et  al.  2008;  WHO  2008),  adverse  effects  on  education  and  economic  growth 
(Bloom et al. 2004; Bloom & Canning 2006), reduced per capita income (Barro & Sala‐I‐Martin 1995; 
Bhargav  et  al.  2001),  and  reduced  foreign  direct  investment  (Alsan  et  al.  2006;  Jones  1990). 
Mortality  and  morbidity  are  often  quantified  in  terms  of  disability‐adjusted  life  years  or  DALYs 
(Homedes 1996; WHO 2004) or lost GDP (for example Armien et al. 2008; Garg et al. 2008). 
Both  anecdotal  and  published  evidence  suggest  that  tourism  can  be  affected  by  Acts  of  God 
(earthquakes,  floods,  hurricanes,  tsunamis,  etc.,  e.g.  Sritama  2005),  socio‐political  instabilities 
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international tourist arrivals from non‐endemic countries have been computed (Table 1) using data 
from  reliable  sources  (Gujarat  Industrial  and  Technical  Consultancy  Organization  Limited  2008; 


































Expenditure  figures  have  been  inflation‐adjusted  using  annual  data  from  the  IMF  (2008)  and 
expressed as 2008 US$, assuming recent market exchange rates of 42.0 INR/US$, 3.22 MYR/US$, 
0.68 EUR/US$, and 33.6 THB/US$. The revenue calculations are shown in full in Appendix A for 





















Page No. 8  W.P.  No.  2009-02-03 





















considerably  among  the  three  countries  and  cannot  be  explained  by  considerations  of 
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stay, different expenditure patterns for business and leisure  travellers, etc., so future  work 
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tourists.  A  better  understanding  of  variation  in  spending  patterns  is  crucial  to  refining  our 














spent  is  seven  (Patel  2009).  This  amount  is  more  than  the  US$  8  million  potential  loss  in 
revenues from international tourists (Table 2). 

























substantial.  In  some  cases,  ignoring  this  component  could  seriously  underestimate  cost‐benefit 
results, forestalling promising interventions that could benefit the society as a whole or leading to 
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Malaysia  1999‐2007  14,000,000  16% 
Mauritius  2002‐2007  754,000  60% 
Réunion  2002‐2004
3  429,000  86% 

























































9  0.04% 6 828
10  0.8%
Malaysia  14,047  1.64% 555 5,914
11  9.4%
Mauritius  1,299  0.15% 1,031 5,043
12  20.4%
Réunion  446  0.05% 556 20,417
12  2.7%







      2005‐06     2006‐07       2007‐08 
Foreign        75,557          97,178       105,127   

































Endemic  1999  2000  2001  2002  2003  2004  2005  2006  2007 
East Asia     6,670,294 8,437,995 10,519,786 11,188,564  8,862,005 13,718,593 14,348,364 15,122,453 17,212,648 
ASEAN
14  Yes  5,947,009  7,194,965  9,208,136  9,885,938  8,042,189  12,491,030  13,238,898  13,856,726  15,620,290 
China  No  190,851  425,246  453,246  557,647  350,597  550,241  352,089  439,294  689,293 
Hong Kong  No  66,981  76,344  144,611  116,409  72,027  80,326  77,528  89,577  94,495 
Japan  No  286,940  455,981  397,639  354,563  213,527  301,429  340,027  354,213  367,567 
Macao  No        2,240  2,953  4,043  5,995 
Mongolia  No        1,438  1,547  2,367  
North Korea  No        10,536  4,689  4,940  8,830 
South Korea  No  41,650  72,443  66,343  64,301  46,246  91,270  158,177  189,464  224,867 
Taiwan  No  136,863  213,016  249,811  209,706  137,419  190,083  172,456  181,829  201,311 
Europe  No  299,647 561,350 611,107 600,296  421,659 507,226 582,456 639,166 774,411 
Oceania   152,039 256,126 252,233 218,951  163,489 227,908 299,192 311,890 361,732 
Australia  No  134,311  236,775  222,340  193,794  144,507  204,053  265,346  277,125  320,363 
New Zealand  No  17,728  19,351  29,893  25,157  18,982  23,855  33,846  34,765  41,369 
The Americas   113,274 253,410 201,722 175,607  171,502 194,894 200,929 229,505 290,325 
Argentina  Yes  1,579  4,984  4,891  1,211  2,030  2,919  4,565  4,388  5,275 












Endemic  1999  2000  2001  2002  2003  2004  2005  2006  2007 
Canada  No  25,987  55,799  38,935  34,996  26,978  32,822  31,167  34,730  46,903 
USA  No  83,260  184,100  145,827  127,920  131,071  145,094  151,354  174,336  204,844 
Mexico  Yes  742 2,846  1,770  2,284  1,491  1,773  1,944  2,588  3,726 
Venezuela  Yes  836 3,258  8,044  6,636  7,748  10,362  9,664  10,468  24,827 
South Asia  Yes  61,841 169,270 186,394 225,415  188,910 233,365 303,823 364,999 648,590 
Middle East  No  21,373 43,418 116,174 123,245  77,735 122,644 144,113 175,474 232,164 
Africa  Yes  12,167 13,661 28,725 21,534  17,877 21,871 21,982 26,674 31,886 
Other  Yes  600,514 486,352 858,932 738,398  673,738 676,905 530,196 676,702 1,421,066 
TOTAL    7,931,149 10,221,582 12,775,073 13,292,010  10,576,915 15,703,406 16,431,055 17,546,863 20,972,822 
Total non‐endemic  1,305,591 2,343,823 2,475,926 2,408,034  1,640,748 2,263,257 2,317,748 2,601,323 3,212,412 












Endemic  2001   2002   2003   2004   2005  2006 
East Asia     6,095,979   6,564,664   6,199,719   7,070,994   6,692,982   7,942,143  
ASEAN
16  Yes  2,393,712   2,623,031   2,654,502   2,936,673   3,099,569   3,556,395  
China  No  695,372   763,708   624,923   780,050   761,904   1,033,305  
Hong Kong  No  531,300   533,798   657,458   664,988   438,519   463,339  
Japan  No  1,179,202   1,233,239 1,026,287   1,194,480   1,181,913   1,293,313  
Korea  No  553,441   717,361   695,034   910,891   815,862   1,101,525  
Taiwan  No  728,953  678,511 525,916  560,198  375,299 472,851
Others  Yes  13,999  15,016 15,599  23,714  19,916 21,415
Europe  No  2,327,680 2,475,319 2,283,913 2,647,682 2,686,567 3,321,795
The Americas   613,897 650,195 586,147 702,675 739,707 825,118
Argentina  Yes  5,674  2,380 1,585  3,018  2,690 3,814
Brazil  Yes  4,258  5,535 4,660  6,275  6,609 8,926
Canada  No  93,006  101,588 97,861  107,505  125,310 149,924
USA  No  494,920  519,668 469,165  566,726  585,476 640,674
Others  Yes  16,039  21,024 12,876  19,151  19,622 21,780












Endemic  2001   2002   2003   2004   2005  2006 
Oceania   430,806 427,014 347,849 471,493 501,882 627,246
Australia  No  366,468  358,616 284,749  396,959  421,594 538,490
New Zealand  No  61,545  65,189 60,545  71,612  77,351 86,703
Others  Yes  2,793  3,209 2,555  2,922  2,937 2,053
Middle East  No  239,200 274,878 206,234 292,680 304,047 405,856
Africa  Yes  91,011 89,535 67,183 82,788 72,873 94,408
TOTAL    10,132,509 10,872,976 10,082,109 11,737,413 11,516,936 13,821,802
Total non‐endemic  7,271,087 7,721,875 6,932,085 8,193,771 7,773,842 9,507,775
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  Non‐Endemic  Endemic 
Venezuela     6,834
*
Vietnam     723
*
Average
17  28,787 5,528
Range (min‐max)  1,216‐89,923 232‐31,028
 
                                                            
17 Not weighed with number of tourists, therefore only indicative of the overall trend 